Cost‐effectiveness of an adherence‐enhancing intervention for gout based on real‐world data

AIM: Medication non‐adherence influences outcomes of therapies for chronic diseases. Allopurinol is a cornerstone therapy for patients with gout; however, non‐adherence to allopurinol is prevalent in Singapore and limits its effectiveness. Between 2008‐2010, an adherence‐enhancing program was implem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lydia Wenxin, Teng, Gim Gee, Lim, Anita Yee Nah, Yoong, Joanne Su‐Yin, Zethraeus, Niklas, Wee, Hwee‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590285/
https://www.ncbi.nlm.nih.gov/pubmed/30556300
http://dx.doi.org/10.1111/1756-185X.13446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590285/
https://www.ncbi.nlm.nih.gov/pubmed/30556300
http://dx.doi.org/10.1111/1756-185X.13446

Ejemplares similares